Ascendis Pharma A/S Reports Third Quarter 2019 Financial Results

    NEXT STORY
    Amarin Highlights Key REDUCE-IT®-Related Data Presented at American Heart Association 2019 Scientific Sessions
    PREV STORY
    Amarin’s John Thero Awarded EY Entrepreneur of The Year® 2019 Life Sciences National Award
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BriaCell Opens Fourth Clinical Site in Advanced Breast Cancer

    BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics ...

    author_avatar
    NASDAQ Market News

    Foamix Announces Completion of Enrollment in Phase 2 Clinical Trial of Minocycline Foam (FMX103) for Treatment of Papulopustular Rosacea

    REHOVOT, Israel and BRIDGEWATER, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. ...

    author_avatar
    NASDAQ Market News

    Global Pharmaceutical Contract Manufacturing Market 2018-2025 – Patent Expiration Of Small Molecules Drugs & Advanced Technologies In API And FDF Manufacturing

    author_avatar
    NASDAQ Market News